PeptiDream Stock

PeptiDream ROE 2024

PeptiDream ROE

0.08

Ticker

4587.T

ISIN

JP3836750004

WKN

A1W0KK

In 2024, PeptiDream's return on equity (ROE) was 0.08, a -68.09% increase from the 0.24 ROE in the previous year.

PeptiDream Aktienanalyse

What does PeptiDream do?

PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding PeptiDream's Return on Equity (ROE)

PeptiDream's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing PeptiDream's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

PeptiDream's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in PeptiDream’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about PeptiDream stock

What is the ROE (Return on Equity) of PeptiDream this year?

The ROE of PeptiDream this year is 0.08 undefined.

How has the Return on Equity (ROE) of PeptiDream developed compared to the previous year?

The ROE of PeptiDream has increased by -68.09% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of PeptiDream?

A high ROE indicates that PeptiDream generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of PeptiDream?

A low ROE can indicate that PeptiDream is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of PeptiDream affect the company?

A change in ROE (Return on Equity) of PeptiDream can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of PeptiDream?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of PeptiDream?

Some factors that can influence PeptiDream's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does PeptiDream pay?

Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.

What is the dividend yield of PeptiDream?

The current dividend yield of PeptiDream is .

When does PeptiDream pay dividends?

PeptiDream pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PeptiDream?

PeptiDream paid dividends every year for the past 0 years.

What is the dividend of PeptiDream?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is PeptiDream located?

PeptiDream is assigned to the 'Health' sector.

Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PeptiDream from 12/15/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 12/15/2024.

When did PeptiDream pay the last dividend?

The last dividend was paid out on 12/15/2024.

What was the dividend of PeptiDream in the year 2023?

In the year 2023, PeptiDream distributed 0 JPY as dividends.

In which currency does PeptiDream pay out the dividend?

The dividends of PeptiDream are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PeptiDream

Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.